Phase 1 study of oral epigallocatechin-3-gallate (EGCG) in IPF patients Grant uri icon

Overview

date/time interval

  • May 20, 2022 - April 30, 2026

sponsor award ID

  • 1 R61 HL158540-01A1

Affiliation